Latigo Biotherapeutics
Clinical trials sponsored by Latigo Biotherapeutics, explained in plain language.
-
New painkiller shows promise in wisdom tooth surgery trial
Symptom relief CompletedThis study tested whether a single dose of LTG-001 can safely reduce pain after wisdom tooth removal. 250 adults took the drug or a placebo and reported their pain levels over 12 hours. The goal was to see if LTG-001 provides faster and more effective pain relief than a dummy pil…
Phase: PHASE2 • Sponsor: Latigo Biotherapeutics • Aim: Symptom relief
Last updated May 15, 2026 11:58 UTC
-
New painkiller shows promise in tummy tuck trial
Symptom relief CompletedThis study tested a new drug called LTG-001 to see if it can safely reduce pain after a tummy tuck (abdominoplasty). About 343 adults took either the drug or a placebo for 48 hours after surgery and reported their pain levels. The goal was to find the best dose and see if it lowe…
Phase: PHASE2 • Sponsor: Latigo Biotherapeutics • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
New pain pill study compares drug absorption in healthy volunteers
Knowledge-focused CompletedThis study looked at how the body absorbs an experimental pain drug called LTG-001 when given as different tablet types. Fourteen healthy adults took single doses of each formulation, and researchers measured drug levels in the blood. The goal was to see which tablet form deliver…
Phase: PHASE1 • Sponsor: Latigo Biotherapeutics • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC